Verapamil Improves the Activity of Bedaquiline against Mycobacterium abscessusIn Vitro and in Macrophages
Albertus Viljoen, Clément Raynaud, Matt D. Johansen, Françoise Roquet‐Banères, Jean‐Louis Herrmann, Wassim Daher, Laurent Kremer
Antimicrobial Agents and Chemotherapy · 2019-06
Abstract
Due to intrinsic multidrug resistance, pulmonary infections with Mycobacterium abscessus are extremely difficult to treat. Previously, we demonstrated that bedaquiline is highly effective against Mycobacterium abscessus both in vitro and in vivo . Here, we report that verapamil improves the efficacy of bedaquiline activity against M. abscessus clinical isolates and low-level resistant strains, both in vitro and in macrophages.
MeSH terms
- Bedaquiline
- Verapamil
- Mycobacterium abscessus
- In vitro
- In vivo
- Microbiology
- Medicine
- Mycobacterium
- Antimycobacterial
- Multiple drug resistance
- Pharmacology
- Mycobacterium tuberculosis
- Antibiotics